Skip to Main Content

Course Objectives

Angiogenesis, Exudation, and Degeneration 2023 – Virtual Edition

Course Objectives

Upon completion of this course, participants should be able to:

  • Examine new evidence for understanding the pathophysiology in nonexudative age-related macular degeneration
  • Examine new evidence for predicting disease progression in nonexudative age-related macular degeneration
  • Evaluate emerging therapies for the treatment of nonexudative age-related macular degeneration with a particular focus on complement inhibitors and the population most likely to benefit once these drugs are approved
  • Evaluate therapies targeting novel disease pathways being investigated in early-stage clinical trials for nonexudative age-related macular degeneration
  • Evaluate the clinical use of available anti-VEGF drugs for exudative ocular diseases
  • Provide an update on the next generation of anti-VEGF therapies recently approved and currently in development
  • Evaluate the benefits and limitations of different imaging technologies in the diagnosis and clinical management of macular and retinal diseases
  • Incorporate the latest advances in artificial intelligence, specifically machine learning, for the diagnosis and treatment of retinal diseases